MDGL – Madrigal Pharmaceuticals Inc
MDGL — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
18.85
Margin Of Safety %
Put/Call OI Ratio
0.43
EPS Next Q Diff
1.16
EPS Last/This Y
7.07
EPS This/Next Y
18.58
Price
510.96
Target Price
659.53
Analyst Recom
1.28
Performance Q
-15.28
Upside
-188.1%
Beta
-1
Ticker: MDGL
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | MDGL | 433.76 | 0.57 | 0.50 | 11943 |
| 2026-03-10 | MDGL | 433.51 | 0.58 | 0.08 | 11916 |
| 2026-03-11 | MDGL | 431.1 | 0.53 | 1.33 | 12536 |
| 2026-03-12 | MDGL | 438.76 | 0.50 | 0.45 | 12426 |
| 2026-03-13 | MDGL | 438.73 | 0.50 | 0.45 | 12426 |
| 2026-03-17 | MDGL | 444.45 | 0.46 | 0.11 | 13068 |
| 2026-03-18 | MDGL | 442.89 | 0.46 | 0.04 | 13105 |
| 2026-03-19 | MDGL | 454.94 | 0.45 | 0.15 | 13232 |
| 2026-03-20 | MDGL | 441.32 | 0.44 | 5.04 | 13545 |
| 2026-03-23 | MDGL | 447.96 | 0.41 | 0.27 | 12680 |
| 2026-03-24 | MDGL | 445.37 | 0.43 | 1.92 | 12905 |
| 2026-03-25 | MDGL | 462.09 | 0.43 | 0.36 | 12908 |
| 2026-03-26 | MDGL | 518.77 | 0.43 | 0.24 | 13045 |
| 2026-03-27 | MDGL | 511.43 | 0.43 | 0.45 | 13802 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | MDGL | 433.67 | -22.3 | 202.0 | -5.73 |
| 2026-03-10 | MDGL | 432.75 | -22.3 | 202.2 | -5.73 |
| 2026-03-11 | MDGL | 431.54 | -22.3 | 202.4 | -5.73 |
| 2026-03-12 | MDGL | 438.42 | -24.8 | 200.9 | -5.78 |
| 2026-03-13 | MDGL | 444.66 | -24.8 | 201.1 | -5.78 |
| 2026-03-17 | MDGL | 443.39 | -24.8 | 196.1 | -5.78 |
| 2026-03-18 | MDGL | 442.46 | -24.8 | 196.6 | -5.78 |
| 2026-03-19 | MDGL | 454.39 | -24.8 | 211.4 | -5.78 |
| 2026-03-20 | MDGL | 441.16 | -24.8 | 213.1 | -5.78 |
| 2026-03-23 | MDGL | 447.51 | -24.8 | 212.3 | -5.78 |
| 2026-03-24 | MDGL | 446.45 | -24.8 | 212.4 | -5.78 |
| 2026-03-25 | MDGL | 461.85 | -24.8 | 210.5 | -5.78 |
| 2026-03-26 | MDGL | 519.15 | -24.8 | 203.1 | -5.78 |
| 2026-03-27 | MDGL | 510.96 | -24.8 | 204.2 | -5.78 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-06 | MDGL | -6.08 | 1.18 | 17.36 |
| 2026-03-09 | MDGL | -6.28 | 1.22 | 17.36 |
| 2026-03-10 | MDGL | -5.98 | 1.22 | 17.36 |
| 2026-03-11 | MDGL | -5.98 | 1.22 | 17.95 |
| 2026-03-12 | MDGL | -5.98 | 1.22 | 17.95 |
| 2026-03-13 | MDGL | -5.98 | 1.22 | 17.95 |
| 2026-03-17 | MDGL | -5.98 | 1.22 | 17.95 |
| 2026-03-18 | MDGL | -5.98 | 1.22 | 17.95 |
| 2026-03-19 | MDGL | -5.98 | 1.22 | 17.95 |
| 2026-03-20 | MDGL | -5.98 | 1.22 | 17.95 |
| 2026-03-23 | MDGL | -5.98 | 1.23 | 17.95 |
| 2026-03-24 | MDGL | -5.98 | 1.23 | 17.95 |
| 2026-03-25 | MDGL | -5.98 | 1.23 | 18.85 |
| 2026-03-26 | MDGL | -5.98 | 1.23 | 18.85 |
| 2026-03-27 | MDGL | -5.98 | 1.23 | 18.85 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-2.57
Avg. EPS Est. Current Quarter
-4.14
Avg. EPS Est. Next Quarter
-1.41
Insider Transactions
-5.98
Institutional Transactions
1.23
Beta
-1
Average Sales Estimate Current Quarter
301
Average Sales Estimate Next Quarter
349
Fair Value
Quality Score
43
Growth Score
28
Sentiment Score
80
Actual DrawDown %
16.9
Max Drawdown 5-Year %
-61.4
Target Price
659.53
P/E
Forward P/E
39.69
PEG
P/S
12.22
P/B
19.35
P/Free Cash Flow
EPS
-12.86
Average EPS Est. Cur. Y
-5.78
EPS Next Y. (Est.)
12.79
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-30.08
Relative Volume
1.33
Return on Equity vs Sector %
-75.2
Return on Equity vs Industry %
-58.9
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-8.13
EBIT Estimation
204.2
◆
MDGL
Healthcare
$510.68
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
68
Range 1M
62%
Sup Dist
10.2%
Momentum Growth
Ride accelerating trends
WATCH
EPS Yr
65.1%
EPS NY
386.7%
52W%
70.8%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-0.5% upside
Upside
-0.5%
Quality
43
Madrigal Pharmaceuticals, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 915
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
MDGL
Latest News
—
Caricamento notizie per MDGL…
stock quote shares MDGL – Madrigal Pharmaceuticals Inc Stock Price stock today
news today MDGL – Madrigal Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MDGL – Madrigal Pharmaceuticals Inc yahoo finance google finance
stock history MDGL – Madrigal Pharmaceuticals Inc invest stock market
stock prices MDGL premarket after hours
ticker MDGL fair value insiders trading